Proper handling and environmental control are essential for preserving the physical and chemical integrity of SS-31 (Elamipretide) in laboratory environments. This technical guide outlines temperature protocols, reconstitution considerations, degradation pathways, and cold-chain parameters required to maintain high baseline purity for in vitro and preclinical research applications.
Proper handling and environmental control are essential for preserving the physical and chemical integrity of SS-31 (Elamipretide) in laboratory environments. This technical guide outlines temperature protocols, reconstitution considerations, degradation pathways, and cold-chain parameters required to maintain high baseline purity for in vitro and preclinical research applications.
SS-31, also designated as Elamipretide or Szeto-Schiller 31, is a synthetic tetrapeptide with the primary amino acid sequence D-Arg-Dmt-Lys-Phe-NH2 (where Dmt represents 2',6'-dimethylL-tyrosine). Unlike conventional linear peptides composed entirely of L-amino acids, the integration of D-amino acids and modified tyrosine residues renders SS-31 naturally resistant to common vascular and tissue peptidases during preclinical evaluation. However, its specific structural motifs remain vulnerable to non-enzymatic degradation pathways when exposed to suboptimal environmental conditions.
The presence of the aromatic 2',6'-dimethyl-L-tyrosine moiety introduces susceptibility to oxidation under ambient light and atmospheric oxygen, while the terminal carboxamide group can undergo hydrolytic cleavage under extreme pH fluctuations. Furthermore, as a basic peptide carrying a net positive charge (+3 at physiological pH), SS-31 exhibits high water solubility but can adsorb to standard borosilicate glass or high-binding plastic surfaces if concentration and container material are not strictly controlled. Understanding these chemical vulnerabilities is necessary to design robust handling protocols for SS-31 research.
In its lyophilized (freeze-dried) state, SS-31 exhibits excellent long-term physical stability provided it is stored under controlled thermal and moisture conditions. Upon receipt from the supplier, desiccated lyophilized vials should be immediately transferred to dedicated laboratory freezer units maintained at -20°C for routine short-to-medium term research storage (up to 12–24 months). For long-term archiving exceeding 24 months, storage at -80°C is recommended to virtually halt molecular motion and baseline chemical degradation kinetics.
Transient exposure to ambient temperatures during transit—such as during standard courier delivery—does not compromise the primary structure of lyophilized SS-31, as solid-state degradation kinetics are negligible over brief timeframes. All PX1 Research orders are fulfilled with same-day shipping (Monday through Friday) originating from our California and Arizona distribution hubs, packaged with temperature-insulating materials to protect the integrity of the cake during transit. Before opening any lyophilized vial, investigators must allow the container to equilibrate to room temperature (20°C to 25°C) for at least 30 to 45 minutes to prevent condensation of atmospheric moisture onto the hygroscopic peptide powder.
Reconstitution is a critical control point where physical shear forces, solvent pH, and bacterial contamination risk can compromise raw material purity. SS-31 reconstitutes rapidly in aqueous media due to its hydrophilic lysine and arginine residues. For standard cell culture or enzymatic assays, sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile unbuffered 0.9% sodium chloride solution (saline) serve as suitable primary diluents.
When preparing stock solutions for physiological or cell culture systems, Phosphate-Buffered Saline (PBS, pH 7.4) may be utilized, provided the final concentration remains within normal solubility thresholds (typically up to 10 mg/mL). Avoid using aggressive organic solvents such as high-concentration dimethyl sulfoxide (DMSO) unless specifically dictated by experimental assay requirements, as polar organic matrices can accelerate oxidative side reactions over time. Review our complete peptide reconstitution guide for exact volumetric calculation models and solvent handling procedures.
Once dissolved in liquid solution, the hydrolysis rate of SS-31 increases substantially compared to its lyophilized form. Reconstituted aqueous solutions stored at 4°C maintain high structural stability for up to 7 to 14 days, assuming non-contaminated sterile conditions. Beyond 14 days at 4°C, minor degradation products—primarily oxidized forms of the dimethyltyrosine residue—may begin to accumulate as detected by liquid chromatography.
Room temperature (20°C–25°C) aqueous solutions of SS-31 demonstrate measurable stability decay within 24 to 48 hours. Exposure to elevated temperatures (>37°C) should be restricted strictly to active assay timeframes. For extended usage patterns, storing reconstituted liquid at sub-zero temperatures (-20°C or -80°C) is mandatory to inhibit peptide bond hydrolysis and amino acid oxidation.
Repeated freeze-thaw cycles represent one of the primary causes of peptide degradation and precipitation in laboratory settings. As an aqueous peptide solution freezes, ice crystals form, causing ice exclusion zones that concentrate both the peptide solute and buffer salts. This micro-environmental shift can induce physical aggregation, pH shifts, and peptide denaturation.
To mitigate freeze-thaw damage, investigators should aliquot the newly reconstituted stock solution into single-use working volumes (e.g., 50 µL to 200 µL) immediately following complete dissolution. Use low-binding polypropylene microcentrifuge tubes to prevent surface adsorption of the charged tetrapeptide. Frozen aliquots kept at -20°C or -80°C should be thawed on ice prior to execution of assays, and any remaining portion of a thawed aliquot should be discarded or kept at 4°C for short-term use rather than refrozen. Further systemic protocols can be evaluated in our broader peptide storage guidelines.
In preclinical studies evaluating mitochondrial bioenergetics and cardiolipin-targeting compounds, SS-31 is often compared alongside other mitochondrial-derived or organelle-targeted peptides. Understanding how the stability of SS-31 compares to structurally distinct compounds aids researchers in designing controlled comparative assays.
While SS-31 gains structural rigidity from its non-canonical D-amino acid modifications, larger mitochondrial peptides exhibit different physical parameters. For instance, MOTS-c—a 16-amino acid peptide encoded from mitochondrial DNA—demonstrates greater secondary structure complexity and requires strict adherence to cold-chain storage parameters as detailed in our MOTS-c storage guide. Similarly, the 24-amino acid peptide Humanin contains hydrophobic regions that render it more prone to self-aggregation in aqueous solutions over prolonged incubation periods than the highly soluble SS-31 tetrapeptide. Consequently, while SS-31 exhibits relatively high aqueous solubility, all three compounds require rigorous sub-zero storage post-lyophilization to prevent enzymatic and chemical breakdown.
The chemical environment surrounding stored SS-31 solutions directly impacts its degradation velocity. SS-31 exhibits maximum stability in slightly acidic to neutral pH ranges (pH 5.0 to 7.0). Strong basic conditions (pH > 8.0) accelerate deamidation and oxidative pathway activation, whereas highly acidic conditions (pH < 3.0) promote hydrolysis of the peptide backbone.
Additionally, photodegradation is a factor for aromatic-containing peptides. Storage vials should be amber-colored glass or clear polypropylene tubes wrapped in aluminum foil to shield the 2',6'-dimethyl-L-tyrosine residue from direct ultraviolet and ambient laboratory lighting. Containers should also be tightly sealed with inert caps to prevent atmospheric oxygen exchange and evaporation during long-term storage in laboratory freezers.
Maintaining rigorous standards across all laboratory reagents is central to reproducible preclinical research. PX1 Research supplies USA-synthesized research peptides processed under ISO 17025 accredited laboratory testing protocols and manufactured within GMP-compliant facilities. Every lot of SS-31 undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to verify chemical identity and guarantee a baseline purity profile of ≥98%.
Furthermore, our compounds undergo strict endotoxin testing to ensure suitablity for sensitive cell culture and in vitro assay systems. Each shipment is accompanied by a lot-specific Certificate of Analysis (COA) documenting verified purity, molecular weight, and analytical chromatography spectra. Research laboratories managing high-throughput screening or bulk research projects can access technical sourcing support through our wholesale lab account portal or explore technical documentation in our research library hub.
What is the optimal long-term storage temperature for lyophilized SS-31?
Lyophilized SS-31 powder should be stored at -20°C for short-to-medium duration storage (up to 12 months) and at -80°C for long-term archiving exceeding 12–24 months.
How long does reconstituted SS-31 remain stable at 4°C?
When reconstituted in sterile aqueous diluent (such as bacteriostatic water or saline), SS-31 maintains structural stability for approximately 7 to 14 days at 4°C before minor oxidative degradation products begin to form.
Why is equilibrating the lyophilized vial to room temperature necessary before opening?
Equilibrating the vial for 30–45 minutes at room temperature prevents atmospheric humidity from condensing on the cold peptide powder inside the vial. Condensed moisture can accelerate hydrolytic degradation and cause the powder to aggregate.
Can SS-31 undergo multiple freeze-thaw cycles after reconstitution?
Multiple freeze-thaw cycles should be strictly avoided. Freeze-thaw stress induces concentration gradients and mechanical shear that lead to physical degradation and aggregation. Stock solutions should be aliquoted into single-use volumes upon reconstitution.
What reconstituting solvents are recommended for SS-31 in laboratory research?
Sterile bacteriostatic water, sterile 0.9% sodium chloride (saline), or standard Phosphate-Buffered Saline (PBS, pH 7.4) are optimal diluents for in vitro research applications.
Does SS-31 require protection from light during laboratory storage?
Yes. SS-31 contains a 2',6'-dimethyl-L-tyrosine modification that can undergo light-catalyzed oxidation. Reconstituted solutions and powder vials should be kept in amber containers or protected from light exposure.
What analytical parameters confirm the purity and quality of PX1 Research SS-31?
PX1 Research verifies each lot using HPLC (for purity ≥98%) and Mass Spectrometry (for identity confirmation), alongside quantitative endotoxin testing in ISO 17025 accredited testing facilities.
How is SS-31 shipped from PX1 Research to preserve stability during transit?
SS-31 is shipped as a stable lyophilized powder using insulated packaging. Orders ship same-day (Monday through Friday) from our California and Arizona facilities to minimize transit times.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.